Mps Limited · NSE:MPSLTD

Mps — Q4 FY26 Earnings Presentation

29 slides from Mps's earnings presentation, 2026

  1. Slide 1: Diverse Perspectives, One Vision: Earnings Presentation Q4 & FY26

    LIMITED DIVERSE PERSPECTIVES, ONE VISION EARNINGS PRESENTATION Q4 & FY26 www.mpslimited.com

  2. Slide 2: Disclaimer

    DISCLAIMER This presentation contains forward-looking statements, inter alia, to enable investors to comprehend the Company’s prospects and take informed investment decisions. This report and other statements — written and oral — that we periodically make, contain forward-looking statements that set

  3. Slide 3: Financial Excellence: Record Earnings & Margin Expansion

    FINANCIAL EXCELLENCE: RECORD EARNINGS & MARGIN EXPANSION Q4 & FY26 Earnings HEADLINE NUMBERS — ALL REPORTED EBITDA FY26 FY26 EBITDA MARGIN X102.11 %236 Cr 30.7% 38.2% YoY: +11.8% Research Segment: 39.9% www.mpslimited.com © 2026 | MPSLimited | 3

  4. Slide 4: Strategic Evolution: Decades of Consistent Expansion

    STRATEGIC EVOLUTION: DECADES OF CONSISTENT EXPANSION From Macmillan Heritage in 1970 to an Al-first Knowledge Solutions Company in 2026 FOUNDATION Founded asa Macmillan India subsidiary Founded in 1970; information processing capabilities established in Bangalore (1976), laying the operational base

  5. Slide 5: Market Opportunity: Leading the AI Transition

    MARKET OPPORTUNITY: LEADING THE Al TRANSITION An $800bn+ market at the Al-led intersection Total Addressable Market TAM - TODAY $187 billion $45 billion $104 billion Projected Market ara ara ama BY 030 $348 billion $95 billion $335 billion Growth Rate 0) 13.30% 16.00% 21.70% CAGR Al-powered medical

  6. Slide 6: Where We Compete: A Defensible Right to Win

    WHERE WE COMPETE: A DEFENSIBLE RIGHT TO WIN Three addressable markets - Combined SAM ~$16bn SAM BOTTOMS-UP MPS Share Today % OF SPEND Scope of Work WHERE MPS PLAYS Growth Pocket WHERE THE SHARE COMES FROM Who We Compete For CUSTOMER PROFILE ~$3 billion ~7-9% Research integrity Al-first production ec

  7. Slide 7: AI at MPS: Production Not Pilot

    Al AT MPS: PRODUCTION NOT PILOT Turns trusted IP into Al products that do not hallucinate Shipping today, Tied to margin and growth outcomes. Alis in revenue, not in slideware — shipping inside flagship products across we operate in. RESEARCH SEGMENT | SEGMENT II EDUCATION SEGMENT III CORPORATE LEAR

  8. Slide 8: FY27 Outlook: Comfortably Crossing the 300 Cr+ EBITDA Mark

    FY27 OUTLOOK: COMFORTABLY CROSSING THE 3300 CR+ EBITDA MARK yr 300+ % cr 2 236 211 169 FY24 FY25 FY26 FY27E MFY24 MFY25 MFY26 DFY27E EBITDA (INR Cr.) www.mpslimited.com FY27 OUTLOOK Based on Current Run Rate, the company is expected to comfortably cross %300 Cr in EBITDA in FY27 FY24 - FY27 - EBITDA

  9. Slide 9: Growth Strategy: A Multi-Pronged Roadmap

    GROWTH STRATEGY: A MULTI-PRONGED ROADMAP 01 COMMERCIAL Go-to-Market Strategy = Refocused market-based strategy to unlock cross-sell synergies across segments. = Client interactions move to a solution-based approach, leveraging firm-wide capabilities. PILLAR, GTM www.mpslimited.com 02 ACCOUNT DEPTH S

  10. Slide 10: Financial Performance Q4 FY26

    FINANCIAL PERFORMANCE Q4 FY26 www.mpslimited.com © 2026 | MPSLimited | 10

  11. Slide 11: Q4 Highlights: Aggressive Core Growth

    Q4 HIGHLIGHTS: AGGRESSIVE CORE GROWTH With steady core business compounding and the integration of Unbound Medicine, the portfolio is well-positioned for sustainable FY27 growth. REPORTED REVENUE a Q4 FY26, YoY a +12.66% Double-digit topline surge. INR 20,516 Lakhs (Q4FY26) vs INR 18,211 Lakhs (Q4FY

  12. Slide 12: Q4 Performance: Expanding Net Profitability

    Q4 PERFORMANCE: EXPANDING NET PROFITABILITY Metrics Q4 FY26 Q4 FY25 YoY Var% Q3 FY26 QoQ Var% Reported Revenue (INR Lakhs) 20,516 18,211 12.66% 18,249 12.42% EBITDA (INR Lakhs) 6,751 5,601 20.53% 5,758 17.25% PAT (INR Lakhs) 4,704 4,707 -0.06% 3,550 32.51% EBITDA (%) 32.90% 30.76% 2.14% 31.55% 1.35%

  13. Slide 13: Core Operations (Excl. AJE): Sustaining High-Margin Growth

    CORE OPERATIONS (EXCL. AJE): SUSTAINING HIGH-MARGIN GROWTH Metrics Q4 FY26 Q4 FY25 YoY Var% Q3 FY26 QoQ Var% Reported Revenue (INR Lakhs) 17,724 14,543 21.87% 15,359 15.40% EBITDA (INR Lakhs) 5,547 4,756 16.63% 4,979 11.41% EBITDA (%) 31.30% 32.70% -1.40% 32.42% -1.12% Headcount 3,146 2,922 7.67% 3,

  14. Slide 14: Research Financials: Consistent Revenue Compounding

    RESEARCH FINANCIALS: CONSISTENT REVENUE COMPOUNDING Q4 FY26 Q4 FY25 Variance YoY Q3 FY26 Variance QoQ Metrics WITH AJE WITHOUT AJE WITH AJE WITHOUT AJE WITH AJE WITHOUT AJE WITH AJE WITHOUT AJE WITH AJE WITHOUT AJE Revenue (INR Lakhs) 11,955 9,164 11,116 7,448 7.55% 23.04% 11,554 8,664 3.47% 5.77% E

  15. Slide 15: Education Financials: Scaling a Profitable Pillar

    EDUCATION FINANCIALS: SCALING A PROFITABLE PILLAR Metrics Q4 FY26 Q4 FY25 Variance YoY Q3 FY26 Variance QoQ Revenue (INR Lakhs) 6,013 4,606 30.55% 4,433 35.64% EBITDA (INR Lakhs) 2,311 1,999 15.61% 1,807 27.89% EBITDA (%) 38.43% 43.40% -4.97% 40.76% -2.33% Headcount 762 754 1.06% 761 0.13% Education

  16. Slide 16: Corporate Learning Financials: Executing a Profitable Pivot

    CORPORATE LEARNING FINANCIALS: EXECUTING A PROFITABLE PIVOT Metrics Q4 FY26 Q4 FY25 Variance YoY Q3 FY26 Variance QoQ Revenue (INR Lakhs) 2,548 2,489 2.37% 2,262 12.64% EBITDA (INR Lakhs) 670 794 -15.62% 431 55.45% EBITDA (%) 26.30% 31.90% -5.60% 19.05% 7.25% Headcount 142 210 -32.38% 145 -2.07% The

  17. Slide 17: Revenue Mix: Balanced and Diversified Portfolio

    REVENUE MIX: BALANCED AND DIVERSIFIED PORTFOLIO Q4FY26 Q3FY26 Q2FY26 Q1FY26 Q4FY25 www.mpslimited.com @ Research @ Education 58.3% 63.3% 61.5% 58.4% 61.0% @ Corporate Learning 29.3% 24.3% 27.2% 27.7% 25.3% 12.4% 12.4% 11.3% 13.9% 13.7% Education is no longer just a supporting player; it is a massive

  18. Slide 18: Diversification: A Sustained Strategic Focus

    DIVERSIFICATION: A SUSTAINED STRATEGIC FOCUS North America 52% 49% 48% Revenue by Geography UK/Europe 33% 31% 35% Rest of the World 15% 20% 17% Debtors DSO (Days) 51 53 53 No. of clients billed 906 467 441 Client Top 5 contribution 45% 41% 46% pivelitcadon Top 10 contribution 59% 55% 59% Top 15 cont

  19. Slide 19: Financial Performance FY26

    FINANCIAL PERFORMANCE FY26 www.mpslimited.com © 2026 | MPSLimited | 19

  20. Slide 20: FY26: The Year in One Line

    FY26 : THE YEAR IN ONE LINE FY26 BASIC EPS +16.3% YoY Highest in company history www.mpslimited.com WHAT WE DID THIS YEAR Acquired Unbound Medicine Closed Feb 2026. Established a healthcare knowledge pillar; 97% gross retention. Reset Corporate Learning cost base Core + flex talent model in place. Q

  21. Slide 21: FY26 Financial Performance: Growth Across the Board

    FY26 FINANCIAL PERFORMANCE: GROWTH ACROSS THE BOARD Metrics FY26 FY25 YoY Change Variance % Reported Revenue (INR Lakhs) 76,837 72,689 +4,148 5.71% EBITDA (INR Lakhs) 23,585 21,090 +2,495 11.83% PAT (INR Lakhs) 17,322 14,891 +2,431 16.32% EBITDA (%) 30.69% 29.01% +1.68% 5.79% PAT (%) 22.54% 20.49% +

  22. Slide 22: FY26 Financial Performance Excl. AJE

    FY26 FINANCIAL PERFORMANCE EXCL. AJE Metrics YoY Change Variance % Reported Revenue (INR Lakhs) 64,573 55,958 +8,615 15.40% EBITDA (INR Lakhs) 19,243 17,249 +1,994 11.56% EBITDA (%) 29.80% 30.82% -1.02% -3.31% Headcount 3,146 2,922 +224 7.67% www.mpslimited.com © 2026 | MPS Limited | 22

  23. Slide 23: Research Solutions: An Anchor with Strong Growth

    RESEARCH SOLUTIONS : AN ANCHOR WITH STRONG GROWTH . FY26 Variance Metrics WITH AJE WITHOUT AJE WITH AJE WITHOUT AJE WITH AJE WITHOUT AJE Reported Revenue (INR Lakhs) 46,351 34,088 45,870 29,139 1.05% 16.98% EBITDA (INR Lakhs) 18,509 14,168 16,800 12,960 10.17% 9.32% EBITDA (%) 39.93% 41.56% 36.63% 4

  24. Slide 24: Education Solutions: Accelerating as a Second Pillar

    EDUCATION SOLUTIONS: ACCELERATING AS A SECOND PILLAR . FY26 FY25 Variance Metrics WITH UB WITHOUT UB WITH UB WITHOUT UB WITH UB WITHOUT UB Reported Revenue (INR Lakhs) 20,890 19,712 15,331 15,331 36.26% 28.58% EBITDA (INR Lakhs) 8,193 7,963 5,746 5,746 42.59% 38.58% EBITDA (%) 39.22% 40.40% 37.48% 3

  25. Slide 25: Revenue Mix: Balanced and Diversified Portfolio

    REVENUE MIX: BALANCED AND DIVERSIFIED PORTFOLIO @ Research @ Education @ Corp. Learning FY26 FY25 www.mpslimited.com © 2026 | MPS Limited | 25

  26. Slide 26: Diversification: A Sustained Strategic Focus

    DIVERSIFICATION: A SUSTAINED STRATEGIC FOCUS North America 50% 45% Revenue by Geography UK/Europe 33% 28% Rest of the World 17% 27% Debtors DSO (Days) 51 53 No. of clients billed 1101 738 Client Top 5 contribution 47% 40% Concentration Top 10 contribution 60% 54% Top 15 contribution 67% 61% CASH FLO

  27. Slide 27: Corporate Social Responsibility (CSR): Activities and Impact

    CORPORATE SOCIAL RESPONSIBILITY (CSR): ACTIVITIES AND IMPACT TOTAL CSR SPENDING AT A CONSOLIDATED LEVEL IS INR 300 LAKHS FOR FY26 Management Education Merit-based scholarships at ISB under the PGP Young Leaders programme, enabling high-potential students to pursue management education. Girls' Educat

  28. Slide 28: CSR Impact Partners

    IMPACT Prem Charitable Trust Sambandh Education Prem Charitable Trust Mental Health APD India KHUSHII Girivanvasi & Vedanta Trusts Disability Support Holistic Development Rural Education www.mpslimited.com © 2026 Limited 28

  29. Slide 29: Thank You

    THANK YOU

MPS — Q4 FY26 Earnings Presentation on 6ix